inVentiv Health target raised to $19 from $17 at Caris
Caris raised its target on inVentiv as it believes that the company's better than expected results show the resilience of the company's outsourcing franchise. The firm maintains an Above Average rating. :theflyonthewall.com
News For VTIV From The Last 14 Days
Check below for free stories on VTIV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
